Innovative systemic therapies for penile cancer

Area of Science:

• Oncology
• Genitourinary Cancers
• Systemic Therapy

Background:

• Penile squamous cell carcinoma (PSCC) is a rare malignancy.
• Limited research funding and systemic therapy development exist for PSCC.
• Advanced PSCC often presents with limited treatment options, especially chemotherapy-refractory disease.

Purpose of the Study:

• To review recent advancements in systemic therapies for penile squamous cell carcinoma.
• To discuss the current understanding of PSCC treatment options.
• To highlight emerging therapeutic targets and their limited clinical evidence.

Main Methods:

• Literature review of recent advancements in PSCC systemic therapy.
• Analysis of current treatment strategies including neoadjuvant chemotherapy and adjuvant therapy.
• Exploration of novel cellular pathways and immune system targets.

Main Results:

• Neoadjuvant chemotherapy and adjuvant therapy are key for locally advanced PSCC.
• New drug regimens are under investigation for first-line options.
• While promising, immunotherapies and targeted pathway inhibitors lack substantial clinical trial evidence for PSCC.

Conclusions:

• PSCC research and funding remain insufficient.
• Despite advancements in understanding cellular pathways and immune targets, clinical application is limited.
• Further clinical and translational research is crucial for improving PSCC treatment outcomes.